R. C. Manak - Concepedia

Author

R. C. Manak

Also Known As

Manak, R C, R C Manak, R. C. Manak, R.C. Manak

Publications

153

Citations

H-Index

Concepts

All Affiliations

R. C. Manak is an author at W.E. Upjohn Institute for Employment Research specializing in pharmacotherapy, medicine, and molecular pharmacology.

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	153
2	Pharmacology	4	4	153
3	Immunology	3	3	129
4	Natural Sciences	1	1	24
5	Biochemistry	1	1	24

R. C. Manak

Publications

153

Citations

H-Index

Page 1

	Year	Citations
Enhancement by tetrahydrouridine of 1-beta-D-arabinofuranosylcytosine (cytarabine) oral activity in L1210 leukemic mice. G L Neil, Thomas E. Moxley, R. C. Manak PubMed ImmunologyPharmacotherapyExperimental PharmacologyTranslational PharmacologyPre-clinical Pharmacology	1970	70
Antitumor effect of 1-beta-D-arabinofuranosylcytosine 5'-adamantoate (NSC 117614) in L1210 leukemic mice. G L Neil, Paul F. Wiley, R. C. Manak, PubMed Chemoprevention StrategyImmunologyPharmacotherapySustained Action EffectTumor Biology	1970	37
Biochemical and pharmacologic studies with 1-β-d-arabinofuranosylcytosine 5′-adamantoate (NSC-117614), a depot form of cytarabine G L Neil, Harold H. Buskirk, Thomas E. Moxley, Biochemical Pharmacology Molecular PharmacologyMedicinal ChemistryPharmaceutical ScienceBiochemistryMedicine	1971	24
Enhancement by tetrahydrouridine (NSC-112907) of the oral activity of 5-azacytidine (NSC-102816) in L1210 leukemic mice. G L Neil, Thomas E. Moxley, Sandra L. Kuentzel, Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) Hematological MalignancyMolecular PharmacologyMedicinal ChemistryOncologyL1210 Leukemia	1975	22

Page 1